Relationship of Initial Pancreatic Enzyme Replacement Therapy Dose With Weight Gain in Infants With Cystic Fibrosis

OBJECTIVE: The aim of the study is to test the hypothesis of a positive relationship between initial dose of pancreatic enzyme replacement therapy (PERT) in infants with cystic fibrosis (CF) and optimal weight gain over the first 2 years of life. METHODS: Using the CF Foundation Patient Registry, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Schechter, Michael S., Michel, Suzanne, Liu, Shufang, Seo, B. Woun, Kapoor, Mudra, Khurmi, Rupal, Haupt, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Original Articles: Pancreatology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155359/
https://www.ncbi.nlm.nih.gov/pubmed/30052568
http://dx.doi.org/10.1097/MPG.0000000000002108

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155359/
https://www.ncbi.nlm.nih.gov/pubmed/30052568
http://dx.doi.org/10.1097/MPG.0000000000002108

Ejemplares similares